Aprovel 300, comprimés pelliculés - 98 Tablette(n) Swissmedic Key 54250142 Registration Holder Sanofi-Aventis (Suisse) SA Name Aprovel 300, comprimés pelliculés Date of registration 15.08.1997 Original/Generic Original Introduction of Sequence 21.12.1999 ATC-Classification Irbesartan (C09CA04) Revision date 26.06.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 93.01 Limitation No Deductible 20 % Consumer price 123.30 Feedback FB Daily cost GTIN 7680542501420 Medication Code Synthetika Pharmacode 3396197 Disponibility
Composition Comprimé pelliculé: irbesartanum 300 mg, lactosum monohydricum 102 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 2.184 mg, hypromellosum, silica colloidalis hydrica, magnesii stearas, pellicule: lactosum monohydricum 7.2 mg, hypromellosum, macrogolum 3000, E 171, cera carnauba, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose additional_information Irbesartan 300 mg Comprimé pelliculé
BAG: Active Agent Dose Irbesartan 300 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum Cera Carnauba E 171 color. Hypromellosum Lactose Monohydrate 7.2 mg pellicule Macrogol 3000 Magnesii Stearas Pro Compresso Obducto Silica Colloidalis Hydrica
Source Data was imported : 05.01.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
